# Partnerships for Advancing Development of Diagnostics for Infectious Diseases (RFA-AI-28-017)

**Plain-English Eligibility Score:** 73/100

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-28-017 |
| Title | Partnerships for Advancing Development of Diagnostics for Infectious Diseases |
| Agency | National Institutes of Health |
| Status | forecasted |
| Posted / open date | 2026-09-24 |
| Close date | Estimated 2027-10-14 |
| Award ceiling | n/a |
| Award floor | n/a |
| Estimated total funding | $10,000,000 |
| Funding category | Health |
| Eligible applicants | Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Public housing authorities/Indian housing authorities; Small businesses; Independent school districts; City or township governments; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Private institutions of higher education; County governments; Special district governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments) |
| Eligibility notes | Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions). |
| CFDA / Assistance listing | 93.855 |
| Summary | The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting partnerships between academic (or small business) investigators and one or more industrial partner(s) for translational development of a diagnostic test that has demonstrated proof-of-concept. Novel diagnostics are needed to implement treatment strategies, evaluate vaccines and identify infectious disease outbreaks, but too often, early diagnostic breakthroughs are not being translated into successful commercial products. Investigators often develop promising diagnostics but then face barriers when navigating the process towards commercialization. The goal is to align investigators wi |
| Agency contact | DMIDDiagnosticsPartnerships@mail.nih.gov |

## Why this score
- Small businesses are listed as eligible applicants.
- Nonprofits are listed as eligible applicants.
- Forecasted: you can prepare before the notice is posted.

Source: Grants.gov (U.S. Department of Health and Human Services) (https://www.grants.gov/search-results-detail/363944). Last refreshed: 2026-11-03T18:08:06.385Z.
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.